Highly Potent Fully Human anti-VISTA Antibodies A New Target Checkpoint Inhibitor against Immunosuppressive Myeloid Cells
Thierry Guillaudeux, PhD, Chief Scientific Officer American Association for Cancer Research (AACR) Virtual Special Conference: Tumor Immunology and Immunotherapy | October 19-20, 2020